I'm curious if any of you have a sense for why this sort of hasn't really penetrated into common practice yet, knowing that there have been other trials over the years
GLP-1RA therapy, when prolonged and potent, may lead to a form of iatrogenic ERM : Short-term gains: lower glucose, lower weight, lower cardiovascular risk Long-term risks: impaired amino-acid balance, reduced re-anabolism, muscle loss, frailty, diminished resilience This progression can be subtle and clinically silentbiochemically detectable long before symptoms appear
Briefly, a total of 119.75 mg of anhydrous LiOH was added to 50 mL of deionized water and stirred for 10 min
Caution is advised in those with kidney disease, and good hydration is important, added Dr